Martha Elba Gonzalez-Mejia

10PUBLICATIONS
8CO-AUTHORS
PharmacogenomicsFood properties (incl. characteristics and health benefits)Te mātai tahumaero o te Māori (Māori epidemiology)Molecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 29, 2025
Dapagliflozin treatment decreases visceral and subcutaneous adipose tissue: a systematic review and meta-analysis.

Carlos U Vargas-Ramírez, Víctor Posadas-Posadas, Renata Ochoa-Précoma

|Apr 14, 2022
Probiotics' effect on visceral and subcutaneous adipose tissue: a systematic review of randomized controlled trials.

Leonardo M Porchia, Gabriela Vazquez-Marroquin, Renata Ochoa-Précoma

|Dec 15, 2021
[Association between metabolic syndrome, socioeconomic status and quality of life in mexicans].

Sergio Kevin Bustamante-Villagómez, Sarahí Vásquez-Alvarez, Martha Elba Gonzalez-Mejia

|Oct 22, 2021
Denosumab improves glucose parameters in patients with impaired glucose tolerance: a systematic review and meta-analysis.

Blanca T Pacheco-Soto, Rebeca Garazi Elguezabal-Rodelo, Leonardo M Porchia

|Apr 26, 2021
Metformin does not improve insulin sensitivity over hypocaloric diets in women with polycystic ovary syndrome: a systematic review of 12 studies.

Samantha Celeste Garcia-Hernandez, Leonardo M Porchia, Blanca T Pacheco-Soto

|Mar 05, 2021
Metabolic Age, an Index Based on Basal Metabolic Rate, Can Predict Individuals That are High Risk of Developing Metabolic Syndrome.

Sarahi Vásquez-Alvarez, Sergio K Bustamante-Villagomez, Gabriela Vazquez-Marroquin

Pageof 2